Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 3
2017 1
2018 5
2019 3
2020 6
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Deep learning DCE-MRI parameter estimation: Application in pancreatic cancer.
Ottens T, Barbieri S, Orton MR, Klaassen R, van Laarhoven HWM, Crezee H, Nederveen AJ, Zhen X, Gurney-Champion OJ. Ottens T, et al. Among authors: klaassen r. Med Image Anal. 2022 Aug;80:102512. doi: 10.1016/j.media.2022.102512. Epub 2022 Jun 7. Med Image Anal. 2022. PMID: 35709559 Free article.
High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1.
Steins A, van Mackelenbergh MG, van der Zalm AP, Klaassen R, Serrels B, Goris SG, Kocher HM, Waasdorp C, de Jong JH, Tekin C, Besselink MG, Busch OR, van de Vijver MJ, Verheij J, Dijk F, van Tienhoven G, Wilmink JW, Medema JP, van Laarhoven HW, Bijlsma MF. Steins A, et al. Among authors: klaassen r. EMBO Rep. 2020 May 6;21(5):e48780. doi: 10.15252/embr.201948780. Epub 2020 Mar 16. EMBO Rep. 2020. PMID: 32173982 Free PMC article.
Rapid stromal remodeling by short-term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma.
Steins A, Klaassen R, Jacobs I, Schabel MC, van Lier MGJTB, Ebbing EA, Hectors SJ, Tas SW, Maracle CX, Punt CJA, Siebes M, Bergman JJGHM, Medema JP, Wilmink JW, Mathot RAA, Strijkers GJ, Bijlsma MF, van Laarhoven HWM. Steins A, et al. Among authors: klaassen r. Mol Oncol. 2020 Apr;14(4):704-720. doi: 10.1002/1878-0261.12599. Epub 2020 Mar 3. Mol Oncol. 2020. PMID: 31733011 Free PMC article.
Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI): prospective pilot study.
Stoop TF, van Veldhuisen E, van Rijssen LB, Klaassen R, Gurney-Champion OJ, de Hingh IH, Busch OR, van Laarhoven HWM, van Lienden KP, Stoker J, Wilmink JW, Nio CY, Nederveen AJ, Engelbrecht MRW, Besselink MG; IMAGE study group. Stoop TF, et al. Among authors: klaassen r. Langenbecks Arch Surg. 2022 Dec;407(8):3487-3499. doi: 10.1007/s00423-022-02653-y. Epub 2022 Oct 15. Langenbecks Arch Surg. 2022. PMID: 36242618 Free PMC article.
Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience.
Klaassen R, Steins A, Gurney-Champion OJ, Bijlsma MF, van Tienhoven G, Engelbrecht MRW, van Eijck CHJ, Suker M, Wilmink JW, Besselink MG, Busch OR, de Boer OJ, van de Vijver MJ, Hooijer GKJ, Verheij J, Stoker J, Nederveen AJ, van Laarhoven HWM. Klaassen R, et al. Mol Oncol. 2020 Sep;14(9):2176-2189. doi: 10.1002/1878-0261.12688. Epub 2020 Jun 23. Mol Oncol. 2020. PMID: 32285559 Free PMC article.
Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer.
Pijnappel EN, Wassenaar NPM, Gurney-Champion OJ, Klaassen R, van der Lee K, Pleunis-van Empel MCH, Richel DJ, Legdeur MC, Nederveen AJ, van Laarhoven HWM, Wilmink JW. Pijnappel EN, et al. Among authors: klaassen r. Cancers (Basel). 2021 Sep 28;13(19):4869. doi: 10.3390/cancers13194869. Cancers (Basel). 2021. PMID: 34638351 Free PMC article.
23 results